Devonian Health Group Inc
OTC:DVHGF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Devonian Health Group Inc (DVHGF) under the Base Case is USD per share.
Compared with the current market price of 4.8 USD, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 4 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Devonian Health Group Does
Devonian Health Group is a biopharmaceutical company that develops prescription drug candidates made from plant-based compounds. Its main work is to research, test, and seek approval for treatments aimed at inflammatory and autoimmune conditions, with a focus on areas such as skin, digestive, and eye diseases. The company does not make consumer health products; it is trying to turn botanical science into regulated medicines.
- Headquarters
- Canada CA
- Employees
- 10
- IPO date
- Sep 9, 2014
Revenue & Expenses Breakdown
Devonian Health Group Inc
Earnings Waterfall
Devonian Health Group Inc
What is the Intrinsic Value of one DVHGF stock?
The intrinsic value for Devonian Health Group Inc (DVHGF) under the Base Case is USD.
Is DVHGF stock undervalued or overvalued?
Compared with the current market price of 4.8 USD, the stock appears .
